Mercury General
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Property & Casualty
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Mercury General (MCY) | 4.51B | 7.01 | 1.61 | 1.56% |
| Chubb Ltd (CB) | 141.99B | 13.03 | 1.94 | 1.07% |
| Progressive (PGR) | 133.67B | 11.66 | 3.88 | 6.01% |
| The Travelers Companies (TRV) | 82.02B | 10.34 | 2.78 | 1.20% |
| Allstate (ALL) | 66.07B | 6.06 | 2.18 | 1.59% |
| WR Berkley (WRB) | 29.09B | 16.56 | 3.03 | 0.49% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 17.4% below Morningstar's fair value estimate.
Fair value
Mercury General Corp receives a 4-star quantitative star rating, illustrating our stance that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 10% discount to our quantitative fair value estimate of $95.59 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The company's profitability increases our quantitative valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 14.1%, which sits in the top 20% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.
The firm's valuation metrics are an additional encouraging factor. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 4.3, a core component of valuation, lies in the bottom 10% globally. Relative to the company's EBITDA, the enterprise value of the business is low, which further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mercury General discussion 0 comments